Navigation Links
Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
Date:10/30/2008

r />

Mylan Inc. and Subsidiaries

Condensed Consolidated Statements of Operations

(unaudited; in thousands, except per share amounts)

Three Months Ended Nine Months Ended

September 30, September 30, September 30, September 30,

2008 2007 2008 2007

Net revenues $1,191,010 $472,400 $3,440,680 $1,498,809

Other revenues 465,838 4,691 493,750 11,865

Total revenues 1,656,848 477,091 3,934,430 1,510,674

Cost of sales 745,711 255,450 2,258,863 757,478

Gross profit 911,137 221,641 1,675,567 753,196

Operating expenses:

Research and development 74,721 33,577 239,320 102,145

Acquired in-process

research and

development - - - 147,000

Impairment loss on

goodwill - - 385,000 -

Selling, general and

administrative 275,584 97,016 787,953 236,684

Litigation settlements,

net - (848) - (4,810)

Total operating expenses 350,305 129,745 1,412,273 481,019

Earnings from operations 560,832 91,896 263,294 272,177

Interest expense 87,553 23,107 264,789 67,010

Other income, net 5,766 166,832 20,583 140,923

Earnings before income

taxes and minority

interest 479,045 235,621 19,088 346,090

Income tax provision 272,438 88,498 197,378 190,455

Earnings (loss) before

minority interest 206,607 147,123 (178,290) 155,635

M
'/>"/>

SOURCE Mylan Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Mylan Announces Pricing of Tender Offers for its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015
2. Mylan to Host Investor Day on October 3, 2007
3. Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD
4. Mylan Announces Appointment of Steven G. Zylstra as Vice President of Global Corporate Communication and Public Relations
5. Mylan Announces Tentative FDA Approval for Lamotrigine Tablets
6. Mylan Announces Final FDA Approval for Balsalazide Disodium Capsules
7. Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement
8. Mylan Announces Final FDA Approval for Ropinirole Hydrochloride Tablets
9. Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
10. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... -- Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual property development ... property, today announced a litigation update. In ... Corp. et al. , Case No. 1:14-cv-00721-GBL-TCB, in the ... Virginia , the Court issued a ... claims in favor of the Defendants on the one ...
(Date:7/1/2015)... TRIANGLE PARK, N.C. and ... agricultural research firm AgBiome, and Genective, key developer ... to accelerate the discovery of new generations of ... traits for insect control to counter the realities ... partner with Genective, aligning AgBiome,s unique insect control ...
(Date:7/1/2015)...  Axovant Sciences Ltd. (NYSE:  AXON), a leading ... dementia, today announced that the company will host ... p.m. EDT following its presentation of RVT-101 clinical ... (AAIC). The event will include ... Lawrence Friedhoff , Chief Development Officer, will present ...
(Date:7/1/2015)... ... July 01, 2015 , ... NEMA 4 (IP66) ... CTI’ new Medical Joysticks have an impermeable molecular barrier protection against bio-hazardous agents. ... device that will increase healthcare worker safety and reduce financial costs. , CTI ...
Breaking Biology Technology:Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3AgBiome and Genective collaborate to create novel insect-resistant crops 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2
... ROCKVILLE, Md., Oct. 31 OriGene Technologies, Inc.,announces ... now in,a GFP (green fluorescence protein) vector, enabling ... over 25,000 human ORF,(open reading frame) clones and ... vector., In early October, the 2008 Nobel ...
... ThermoGenesis,Corp. (Nasdaq: KOOL ), a leading supplier of ... today it will report,financial results for the fiscal first ... Company,s Conference Call and Webcast, Management will ... PM Pacific (5:00 PM Eastern) to review the fiscal ...
... Sharps Compliance Corp. (OTC,Bulletin Board: SCOM) ("Sharps" ... solutions for small quantity generators of medical,waste, today ... the,Company,s President and Chief Operating Officer, effective October ... of the Company,s Board of Directors,since October of ...
Cached Biology Technology:OriGene Announces 37,000 ORF cDNA Clones in a GFP Vector 2ThermoGenesis Corp. to Announce First Quarter Fiscal 2009 Results on November 6, 2008 2Sharps Compliance Corp. Announces Appointment of John R. Grow as President and Chief Operating Officer 2Sharps Compliance Corp. Announces Appointment of John R. Grow as President and Chief Operating Officer 3
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/km7m5t/natural_language ... "Natural Language Processing Market by Type (Rule-Based, Statistical, ... Image Recognition) - Worldwide Forecast to 2020" ... vendors occupying the market are 3M, Apple, Dolbey ... Solutions, SAS Institute Inc., Verint Systems among various ...
(Date:7/2/2015)... , June 25, 2015 ... addition of the "Next Generation Biometrics Market by ... 2020" report to their offering. The ... Billion by 2020, at a CAGR of 17.9% between ... the leading application for the market. Safran SA ...
(Date:7/2/2015)... Sweden , July 2, 2015 ... sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor World ... one of FPC,s distributors in Asia . ... 2015. The sensors will be used by smartphone manufacturers in ... MSEK is included in the communicated revenue guidance of approximately ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... tool, a searchable database known ... in Florida," was developed by ... the University of Florida, the ... the U.S. Geological Survey, and ...
... Obesity is a major contributor to heart disease that substantially ... researching the impact of obesity and weight loss on the ... the country,s problem is only going to get worse, said ... Medical College of Georgia Section of Cardiology at Georgia Health ...
... lack the ability to adapt effectively to predicted increases ... near future, according to new research. In ... National Academy of Sciences , researchers from Monash University, ... many species of fruit fly appear to be constrained ...
Cached Biology News:Obesity is major contributor to heart disease, impediment to diagnosis and treatment 2Obesity is major contributor to heart disease, impediment to diagnosis and treatment 3Evolutionary straitjacket means flies can't take the heat 2
Goat polyclonal to Centaurin alpha 2**...
... signal and low background ,This solution greatly ... times higher than obtained with conventional methods. ... primary and secondary antibodies, which can suppress ... , Wide versatility ,It is applicable ...
Monocarboxylate (lactate) transporter 2...
Mouse anti human pro-Relaxin-2...
Biology Products: